TY - JOUR T1 - Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’ JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis DO - 10.1136/annrheumdis-2020-218950 SP - annrheumdis-2020-218950 AU - Zhuochao Zhou AU - Fan Wang AU - Yue Sun AU - Jialin Teng AU - Honglei Liu AU - Xiaobing Cheng AU - Yutong Su AU - Hui Shi AU - Yijun You AU - Chengde Yang AU - Junna Ye Y1 - 2020/10/01 UR - http://ard.bmj.com/content/early/2020/09/30/annrheumdis-2020-218950.abstract N2 - 2019 antiphospholipid syndrome (APS) guideline1 has been launched and has given recommendations to the rheumatologists on how to manage APS in different situations. The guideline has been presented in detail but there are still some questions remain to be discussed. For example, we are still confused in some circumstances, in secondary APS, such as systemic lupus erythematous, glucocorticoids (GC) is widely used. But according to the guideline in primary APS, GC treatment is recommended only in first trimester of pregnancy or in catastrophic APS (CAPS). But … ER -